Aspro. Armorel Van Eyk

Armorel Van Eyk is a pharmaceutical scientist whose work spans drug delivery, infectious diseases, and bioactive compound development. With a strong foundation in pharmaceutics and pharmacotherapy, research integrates nanotechnology, analytical chemistry, and biomaterials to address pressing clinical challenges, particularly tuberculosis and antimicrobial resistance.

Recent publications highlight advances in surface-modified nanosystems for targeted tuberculosis therapy and host-directed immunomodulatory strategies, reflecting a focus on improving treatment efficacy and limiting resistance. Analytical method development, including rapid HPLC techniques for antitubercular agents and steroid hormones, demonstrates expertise in drug quantification and translational pharmacokinetics.

Additional contributions include the design of collagen-mimetic peptide hydrogels for wound healing, metal-based anticancer complexes, and validation of ethnopharmacological treatments for skin disease. Clinical review articles on respiratory infections, conjunctivitis, and sexually transmitted infections further illustrate engagement with evidence-based therapeutic practice and public health in the South African context.